Epstein-Barr virus cause of multiple sclerosis

Current Opinion in Rheumatology

Volumn 24, Issue 4, 2012, Pages 424-428

  Tselis, Alex ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epstein Barr virus; multiple sclerosis; viral cause of multiple sclerosis; viral demyelination

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; OLIGOCLONAL BAND; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ANTIBODY PRODUCTION; ANTIBODY TITER; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROPREVALENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS TRANSMISSION; WHITE MATTER;

ANTIBODIES, VIRAL; BRAIN; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 84862123953     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283542cf8     Document Type: Review

References (44)

1. Warner H, Carp R. Multiple sclerosis and Epstein-Barr virus. Lancet 1981; 2:1290.
2. Black F, Hierholzer W, Pinheiro F, et al. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol 1974; 100:230-250.
3. Neiderman J, Evans A, Subrahmanyan M, McCollum R. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med 1970; 282:361-365.
4. Biggar RJ, Henle G, Bocker J, et al. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer 1978; 22:244-250. (Pubitemid 9024590)
5. Colby BM, Shaw JE, Elion GB, Pagano JS. J Effect of acyclovir on Epstein-Barr virus DNA replication. J Virol 1980; 34:560-568.
6. Foss H, Herbst H, Hummel M, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994; 83:707-712. (Pubitemid 24043731)
7. Pattengale P, Smith B, Perlin E. Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. N Engl J Med 1974; 291:1145-1148.
8. Bray P, Culp K, McFarlin D, et al. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 1992; 42:278-282.
9. Operskalski E, Visscher B, Malmgren R, Detels R. A case-control study of MS. Neurology 1989; 39:825-829.
10. Haahr S, Koch-Henriksen N, Moller-Larsen A, et al. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Acta Neurol Scand 1997; Suppl 169:70-75. (Pubitemid 27223447)
11. Thacker E, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006; 59:499-503. (Pubitemid 43358070)
12. Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in chldren with multiple sclerosis. Neurology 2006; 67:2036-2065.
13. Bray P, Bloomer L, Salmon V, et al. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983; 40:406-408. (Pubitemid 13060499)
14. Larsen P, Bloomer L, Bray P. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 1985; 35:435-438. (Pubitemid 15100694)
15. Myhr K, Riise T, Barrett-Connor E, Myrmel H, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998; 64:539-542. (Pubitemid 28195960)
16. Shirodaria P, Haire M, Fleming E, et al. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 1987; 44:1237-1241. (Pubitemid 18004933)
17. Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875-1879. (Pubitemid 38509501)
18. Ascherio A, Munger K, Lennette E, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286:3083-3088. (Pubitemid 34016522)
19. Sundstrom P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62:2277-2282. (Pubitemid 38787787)
20. Levin L, Munger K, Rubertone M, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293:2496-2500. (Pubitemid 40705731)
21. DeLorenze G, Munger K, Lennette E, et al. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long term followup. Arch Neurol 2006; 63:839-844. (Pubitemid 43882291)
22. Sumaya C, Myers L, Ellison G, Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985; 17:371-377. (Pubitemid 15079065)
23. Bray P, Luka J, Bray P, et al. Antibodies against Epstein-Barr nuclear antigen in multiple sclerosis CSF and two pentapeptide sequence between EBNA and myelin basic protein. Neurology 1992; 42:1798-1804.
24. Rand K, Houck H, Denslow N, Heilman K. Molecular approach to find targets for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65:48-55. (Pubitemid 28302356)
25. Sargsyan S, Shearer A, Rictchie A, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with mulitple sclerosis. Neurology 2010; 74:1127-1135.
26. Pohl D, Rostasy K, Jacobi C, et al. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol 2010; 257:212-216.
27. Jafari N, Van Nierop G, Verjans G, et al. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear angen-1 in multiple sclerosis. J Clin Virol 2010; 49:26-31.
28. Otto C, Oltmann A, Stein A, et al. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology 2011; 76:1316-1321.
29. Owens G, Bennett J, Lassmann H, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 2009; 65:639-649.
30. Wucherpfennig K, Strominger J. Molecular mimicry in cell-mediated autoimmunity: viral peptides activate human cell clones specific for myelin basic protein. Cell 1995; 80:695-705.
31. Lang H, Jacobsen H, Ikemizu S, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3:940-943. (Pubitemid 35154007)
32. Holmoy T, Vartdal F. Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed cells. J Neurovirol 2004; 10:52-56. (Pubitemid 38325109)
33. Holmoy T, Kvale E, Vartdal F. Cerebrospinal fluid CD4 + T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol 2004; 10:278-283. (Pubitemid 39429938)
34. Lunemann J, Edwards N, Muraro P, et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006; 129:1493-1506. (Pubitemid 43999382)
35. Nielsen T, Rostgaard K, Nielsen N, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64:72-75. (Pubitemid 46072426)
36. Hilton D, Love S, Fletcher A, Pringle J. Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridization. J Neurol Neurosurg Psychiatry 1994; 57:975-976. (Pubitemid 24251065)
37. Morre S, Van Beek J, De Groot C, et al. Is Epstein-Barr virus present in the CNS of patients with MS? Neurology 2001; 56:692. (Pubitemid 32210014)
38. Sanders V, Felisan S, Waddell A, Tourtellotte W. Detection of herpesviridae in postmortem multiple sclerosis brain tissue anc controls by polymerase chain reaction. J Neurovirol 1996; 2:249-258. (Pubitemid 26285269)
39. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204:2899-2912. (Pubitemid 350179559)
40. Willis S, Stadelmann C, Rodig S, et al. Epstein-Barr virus infection is not a characteristic feature of mulitple sclerosis brain. Brain 2009; 32:3318-3328.
41. Peferoen L, Lamers F, Lodder L, et al. Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010; 133:1-4.
42. Aloisi F, Serafini B, Magliozzi R, et al. Detection of Epstein-Barr virus and Bcell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain 2010; 133:1-5.
43. Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue: report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011; 134:2772-2786.
44. Tzarros J, Khan G, Vossenkamper A, et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 2012; 78:15-23.